United States · Bill · HR
H.R. 7917 (116th)
IGNITE American Innovation Act
Introduced
31 July 2020
Last action
—
Status
Referred to the Subcommittee on Select Revenue Measures.
Sponsors
—
Subjects
Discovery layer
Source updated
3 January 2025
Summary
Innovation and Growth Now by Investing in Tomorrow's Enterprises Act or the IGNITE American Innovation Act This bill allows certain C corporation taxpayers to elect an increased advance refund of net operating loss carryovers attributable to COVID-19 (i.e., coronavirus disease 2019) research expenditures in 2020 and 2021. The bill also allows such taxpayers an advance refund of certain other net operating loss carryovers arising during 2015 through 2021. The bill allows an increased research tax credit for COVID-19 research expenditures paid or incurred on or after February 15, 2020, and before January 1, 2022.
This text is taken from the official record. PoliticalRepo does not editorialize.
Timeline
No timeline events have been ingested for this record yet.
Votes
No vote records are attached yet.
Versions
No version snapshots stored. Document URLs remain at the source.
Documents
3 official files
Introduced in House (text)
Introduced in House (text)
Introduced in House · EN · 31 July 2020
Introduced in House (PDF)
Introduced in House · EN · 31 July 2020
Introduced in House
summary · EN · 31 July 2020
Sponsors
No sponsors or actors listed by the source.
Related records
No cross-record relationships stored yet.
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://www.congress.gov/bill/116th-congress/house-bill/7917
- Open data entity: https://api.congress.gov/v3/bill/116/hr/7917